We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 21-40 of 241 results
  1. Use of glucocorticoids and azithromycin in the therapy of COVID-19

    In December 2019, a new variant coronavirus, SARS-CoV-2, emerged in China, which was initially described as a pneumonia of an unknown agent. The new...

    Miguel de Lemos Neto, Rafael Costa Vieira Alexandre, ... Pedro Celso Braga Alexandre in Pharmacological Reports
    Article 04 June 2021
  2. Phase I and phase II metabolite identification of rutaecarpine in freshly isolated hepatocytes from male Sprague–Dawley rats

    Rutaecarpine, an alkaloid originally isolated from Evodia rutaecarpa , has been used for the treatment of gastrointestinal disorders in Asia. In the...

    Dong Wook Lee, Youra Kang, ... Tae Cheon Jeong in Archives of Pharmacal Research
    Article 10 August 2017
  3. Relationship between plasma exposure of zolpidem and CYP2D6 genotype in healthy Korean subjects

    Zolpidem, a widely prescribed hypnotic agent, is extensively metabolized by cytochrome P450 (CYP) 3A4, and CYP2C9, CYP1A2 and CYP2D6 are also...

    Eui Hyun Jung, Choong-Min Lee, ... Yun Jeong Lee in Archives of Pharmacal Research
    Article 13 July 2020
  4. Coronavirus Disease 2019 and Herbal Therapy: Pertinent Issues Relating to Toxicity and Standardization of Phytopharmaceuticals

    Coronavirus disease 2019 (COVID-19) is a virulent viral disease that has now become a public health emergency of global significance and still...

    Kayode Komolafe, Titilope Ruth Komolafe, ... Afolabi Akintunde Akindahunsi in Revista Brasileira de Farmacognosia
    Article 11 March 2021
  5. Cryptotanshinone ameliorates placental oxidative stress and inflammation in mice with gestational diabetes mellitus

    Gestational diabetes mellitus (GDM) is a conditional diabetes which is defined as any degree of glucose intolerance or high blood glucose levels...

    Na Wang, **ujuan Dong, ... Qun Zhang in Archives of Pharmacal Research
    Article 29 June 2020
  6. Drug repurposing approach to fight COVID-19

    Currently, there are no treatment options available for the deadly contagious disease, coronavirus disease 2019 (COVID-19). Drug repurposing is a...

    Thakur Uttam Singh, Subhashree Parida, ... Raj Kumar Singh in Pharmacological Reports
    Article 05 September 2020
  7. Phytochemical and pharmacological properties of Myristica fragrans Houtt.: an updated review

    Myristica fragrans Houtt. (Myristicaceae), an aromatic evergreen tree, is well known as a commercial source of mace (aril) and nutmeg (seed), which...

    Manh Tuan Ha, Ngoc Khanh Vu, ... Byung Sun Min in Archives of Pharmacal Research
    Article 18 November 2020
  8. Development of a column-switching LC-MS/MS method of tramadol and its metabolites in hair and application to a pharmacogenetic study

    Hair is a valuable specimen for monitoring long-term drug use. Tramadol is an effective opioid analgesic but is associated with risks such as drug...

    Hyerim Yu, Minje Choi, ... Sooyeun Lee in Archives of Pharmacal Research
    Article 09 March 2018
  9. Ortho-vanillin nanoparticle-doped glucan microspheres exacerbate the anti-arthritic effects of methotrexate in adjuvant-induced arthritis in rats

    Background

    Methotrexate (MTX) commonly used in rheumatoid arthritis (RA) has severe adverse effects. Ortho-vanillin, an inhibitor of Toll-like...

    Shiva Nasr, Jaleh Varshosaz, Valiolah Hajhashemi in Pharmacological Reports
    Article 09 April 2020
  10. Drug-drug interaction potential of antitumor acridine agent C-1748: The substrate of UDP-glucuronosyltransferases 2B7, 2B17 and the inhibitor of 1A9 and 2B7

    Background

    The compound 9-(2′-hydroxyethylamino)-4-methyl-1-nitroacridine (C-1748), the promising antitumor agent developed in our laboratory was...

    Anna Mróz, Izabela Ryska, ... Zofia Mazerska in Pharmacological Reports
    Article Open access 22 March 2018
  11. Intestinal drug transporters in pathological states: an overview

    Emerging information suggests that gastrointestinal and systemic pathology states may affect expression and function of membrane transporters in the...

    Marek Drozdzik, Izabela Czekawy, ... Agnieszka Drozdzik in Pharmacological Reports
    Article Open access 27 July 2020
  12. Transplant drugs affect the expression of phase II and antioxidant enzymes in human carcinoma cells HepG2 but not in primary cultures of human hepatocytes: In vitro comparative study

    Background

    We carried out a test whether or not transplant drugs such as cyclosporine A, Rapamycin (Sirolimus), Tacrolimus, Everolimus and...

    Radim Vrzal, Peter Illes, Zdenek Dvorak in Pharmacological Reports
    Article 17 July 2016
  13. Mitochondrial biology in airway pathogenesis and the role of NRF2

    A constant improvement in understanding of mitochondrial biology has provided new insights into mitochondrial dysfunction in human disease...

    Hye-Youn Cho, Steven R. Kleeberger in Archives of Pharmacal Research
    Article 04 September 2019
  14. Modulation of UDP-glucuronidation by acridinone antitumor agents C-1305 and C-1311 in HepG2 and HT29 cell lines, despite slight impact in noncellular systems

    Background

    Among the studied antitumor acridinone derivatives developed in our laboratory, 5-dimethylaminopropylamino-8-hydroxytriazoloacridinone...

    Anna Bejrowska, Monika Pawłowska, ... Zofia Mazerska in Pharmacological Reports
    Article 22 November 2017
  15. Inhibition of cytochrome P450 3A enzyme by Millettia aboensis: its effect on the pharmacokinetic properties of efavirenz and nevirapine

    The chronic and comorbid nature of HIV infection necessitate the use of multiple drugs including herbs to relieve symptoms with a possible increase...

    Sunday O. Nduka, Mathew J. Okonta, ... Chinwe V. Ukwe in Revista Brasileira de Farmacognosia
    Article Open access 15 December 2016
  16. Prediction of drug–drug interaction potential using physiologically based pharmacokinetic modeling

    The occurrence of drug–drug interactions (DDIs) can significantly affect the safety of a patient, and thus assessing DDI risk is important. Recently,...

    Jee Sun Min, Soo Kyung Bae in Archives of Pharmacal Research
    Article 27 October 2017
  17. Reduce the risk of QT interval prolongation associated with targeted cancer therapy by using arrhythmic risk stratification and prevention strategies

    QT interval prolongation, a cardiotoxicity that increases the risk of fatal arrhythmia, is associated with several targeted cancer therapies,...

    Article 13 July 2017
  18. Recent advances in pharmacological research on Ecklonia species: a review

    The genus Ecklonia (Lessoniaceae, Phaeophyceae), commonly called kelp (brown algae), is abundant on the coasts of Japan and Korea. During the past...

    Prashamsa Koirala, Hyun Ah Jung, Jae Sue Choi in Archives of Pharmacal Research
    Article 24 August 2017
  19. Effects of friedelin on the intestinal permeability and bioavailability of apigenin

    Background

    Although apigenin possesses diverse pharmacological activities, its utilization as a bioactive substance is limited by poor oral...

    **-Ah Lee, Sang Keun Ha, ... Inwook Choi in Pharmacological Reports
    Article 23 April 2017
  20. Structures of Cytochrome P450 Enzymes

    The protein database has >  450 entries with P450 in the title and of these there are approximately 54 unique structures. Although this sample of...
    Thomas L. Poulos, Eric F. Johnson in Cytochrome P450
    Chapter 2015
Did you find what you were looking for? Share feedback.